Clinical trial Recruiting at 1 site Interventional Ages 65 to 85

Upper limb motor control training for cognitive function in older adults

Official title: The Effect of Upper Limb Low-intensity Motor Control Training (uMCON) Program on Cognitive Function in Healthy Older Adults: A Pilot Study

Run by University of Nottingham · NCT06962722 · Data updated 2026-11-12

This study is testing if a special training program for arm movements can help healthy older adults improve their physical skills and thinking abilities.

Quick facts

Study typeInterventional
Ages65 Years to 85 Years
SexAll
Enrollment24 (estimated)
SponsorUniversity of Nottingham
Academic / other
Locations1 site (Derby, Derbyshire)
StatusRecruiting
StartedSeptember 1, 2023
Main results expectedMay 31, 2026
Study endsMay 31, 2026
Registry record updatedMay 8, 2025
Trial IDNCT06962722 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are healthy older adults aged 65-85 who are willing to participate and provide informed consent.

Probably not a fit

Patients with diagnosed cognitive impairment or significant medical conditions such as cardiovascular or neurological diseases may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This intervention study evaluates the effectiveness of upper limb motor control training (uMCT) on both physical and cognitive functions in healthy older adults aged 65-85. Participants will be randomized into either the uMCT group or a no-intervention control group, with assessments conducted before and after a 4-week training period. The study aims to determine if uMCT can enhance motor coordination, neuromuscular function, and cognitive abilities while also assessing the feasibility and safety of the training program. Participants will undergo screening and assessment sessions to ensure their eligibility and safety throughout the study.

Why it matters

Potential benefit: If successful, this training program could improve cognitive and physical functions in older adults, potentially enhancing their quality of life.

How similar studies have gone: While similar approaches have been explored, this specific intervention focusing on upper limb motor control training in healthy older adults is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* • Willing and able to give informed consent for participation in the study

  * Aged between 65-85 years

Exclusion Criteria:

* • Diagnosis of cognitive impairment

  * Current or recent (\<5y) malignancy
  * History of or current psychiatric illness
  * History of or current neurological condition (e.g., epilepsy, Parkinsons disease, cerebrovascular disease)
  * Severe respiratory disease (e.g., uncontrolled asthma, COPD, pulmonary hypertension)
  * Active cardiovascular disease: Uncontrolled hypertension (BP\>160/100mmHg); Recent (\<12mo) cardiac event; Heart failure (Class III/IV); Significant arrhythmia; Unstable angina
  * Metabolic disease: Untreated hyper/hypo-parathyroidism; Cushing's disease; Type 1 or 2 diabetes
  * Significant musculoskeletal disorders (based on clinical opinion)
  * Family history of early (\<55y) death from cardiovascular disease

Where it's running

  • The University of Nottingham Medical School
    Derby, Derbyshire, United Kingdom
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.